Used in pharmaceutical research as a potent serotonin 5-HT1B receptor agonist, this compound is investigated for its potential in treating neurological and psychiatric disorders, particularly migraine. Its selective action on 5-HT1B receptors makes it valuable in studying vascular constriction and neurotransmission modulation. Due to its structural specificity and high affinity for serotonin receptors, it serves as a key reference compound in the development of new antimigraine agents and in neuropharmacological assays assessing receptor activity and drug efficacy.